Abstract:In recent years, the most common pharmacological treatment for Alzheimer's disease (AD) has been acetylcholinesterase (AChE) inhibition. However, this single-target approach has limited effectiveness and there is evidence that a multitarget approach might be more effective. Huperzine A (HupA), a novel alkaloid isolated from a Chinese herb, has neuroprotective effects that go beyond the inhibition of AChE. Recent data have demonstrated that HupA can ameliorate the learning and memory deficiency in animal models and AD patients. Its potentially beneficial actions include modification of β-amyloid peptide processing, reduction of oxidative stress, neuronal protection against apoptosis, and regulation of the expression and secretion of nerve growth factor (NGF) and NGF signaling. In recent years, the most common pharmacological treatment for Alzheimer's disease (AD) has been acetylcholinesterase (AChE) inhibition. However, this single-target approach has limited effectiveness and there is evidence that a multitarget approach might be more effective. Huperzine A (HupA), a novel alkaloid isolated from a Chinese herb, has neuroprotective effects that go beyond the inhibition of AChE. Recent data have demonstrated that HupA can ameliorate the learning and memory deficiency in animal models and AD patients. Its potentially beneficial actions include modification of β-amyloid peptide processing, reduction of oxidative stress, neuronal protection against apoptosis, and regulation of the expression and secretion of nerve growth factor (NGF) and NGF signaling. an enzyme found in most plant and animal cells that functions as an oxidative catalyst. It decomposes hydrogen peroxide into hydrogen and water. a series of enzymatic reactions in aerobic organisms involving oxidative metabolism of acetyl units and producing high-energy phosphate compounds, which serve as the main source of cellular energy. optically rotating to the right. The rotation of interest in chemistry is induced by a chiral molecule. The direction of rotation cannot be predicted from the R or S designation of the configuration at the stereocenter: in some cases the R isomer is dextrorotatory and the S isomer is levorotatory, whereas in other cases it is the other way around. an enzyme in the body that is a powerful scavenger of free radicals; it helps to prevent peroxidation of cell membranes by consuming free peroxide in the cell. optically rotating to the left. The levorotatory isomer of optically active compounds is the form usually found in nature. a by-product of lipid metabolism in the body. It is also found in many foods and can be present in high amounts in rancid food. an enzyme that catalyzes the decomposition of a superoxide into hydrogen peroxide and oxygen. a transgenic mouse strain that overexpresses a mutant form of human amyloid precursor protein with the Swedish mutation (APPSw), resulting in high Aβ levels in the brain. a dementia that is caused by disease of the blood vessels of the brain (cerebrovascular disease). It is the second most common form of dementia after AD.

Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease

Acetylcholinesterase-independent protective effects of huperzine A against iron overload-induced oxidative damage and aberrant iron metabolism signaling in rat cortical neurons

Huperzine A As Potential Treatment Of Alzheimer'S Disease: An Assessment On Chemistry, Pharmacology, And Clinical Studies

Neuroprotective Effects of Huperzine A: New Therapeutic Targets for Neurodegenerative Disease

Huperzine A, A Potential Therapeutic Agent for Treatment of Alzheimer's Disease

Decreased accumulation of subcellular amyloid-β with improved mitochondrial function mediates the neuroprotective effect of huperzine A

Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine

Huperzine A Activates Wnt/β-Catenin Signaling and Enhances the Nonamyloidogenic Pathway in an Alzheimer Transgenic Mouse Model

Huperzine A Regulates the Physiological Homeostasis of Amyloid Precursor Protein Proteolysis and Tau Protein Conformation—A Computational and Experimental Investigation

Non-cholinergic Effects of Huperzine A: Beyond Inhibition of Acetylcholinesterase

Iron and Alzheimer’s Disease: From Pathogenesis to Therapeutic Implications

Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer’s disease: an updated meta-analysis

Huperzine A in the Treatment of Alzheimer's Disease and Vascular Dementia: A Meta-Analysis

Protective Effects Of Huperzine A On Beta-Amyloid(25-35) Induced Oxidative Injury In Rat Pheochromocytoma Cells

Effective components of Chinese herbs reduce central nervous system function decline induced by iron overload

Hepcidin Overexpression in Astrocytes Alters Brain Iron Metabolism and Protects Against Amyloid-Β Induced Brain Damage in Mice

Involvement of Intracellular and Mitochondrial Aβ in the Ameliorative Effects of Huperzine A Against Oligomeric Aβ42-Induced Injury in Primary Rat Neurons

Astrocyte Hepcidin Ameliorates Neuronal Loss Through Attenuating Brain Iron Deposition and Oxidative Stress in APP/PS1 Mice.

Compound of icariin, astragalus, and puerarin mitigates iron overload in the cerebral cortex of Alzheimer's disease mice

O4‐04–06: Huperzine A for Alzheimer's Disease

Evaluation of the in Vitro and in Vivo Metabolic Pathway and Cytochrome P450 Inhibition/induction Profile of Huperzine A.